A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2011
10/26/2011	CN101585880B Variable regions on heavy and light chains of antihuman IL-13R alpha 2 monoclonal antibodies
10/26/2011	CN101475943B Rabies viruses CTN strain complete genome infectious cDNA cloning, and preparation and use thereof
10/25/2011	US8044259 Determining the capability of a test compound to affect solid tumor stem cells
10/25/2011	US8044189 Bacillus anthracis protective antigen nucleic acid sequences
10/25/2011	US8044185 Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopes
10/25/2011	US8044183 Process for the production of immunogenic compositions
10/25/2011	US8044180 FcγRIIB specific antibodies and methods of use thereof
10/25/2011	US8044179 Methods and compositions for modulating tumor cell activity
10/25/2011	US8044178 Anti-5T4 antibodies and uses thereof
10/25/2011	US8044025 Urocortin proteins and uses thereof
10/25/2011	US8043856 Adenoviral vectors for influenza virus production
10/25/2011	US8043831 Therapeutic agents comprising pro-apoptotic proteins
10/25/2011	US8043625 Purified plasmodium and vaccine compositions
10/25/2011	US8043624 Compositions and methods for treatment of microbial infections
10/25/2011	US8043623 Immunogenic peptides for the treatment of prostate and breast cancer
10/25/2011	US8043622 Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides
10/25/2011	US8043621 Recombinant fusion protein and polynucleotide construct for immunotoxin production
10/25/2011	US8043620 Wise binding agents and epitopes
10/25/2011	US8043619 Methods and uses of leptin in immune modulation
10/25/2011	US8043618 Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment
10/25/2011	US8043617 Human antibodies to human IL-6 receptor
10/25/2011	US8043616 sRAGE mimetibody, compositions, methods and uses
10/25/2011	US8043615 Methods of antagonizing LDCAM and CRTAM
10/25/2011	US8043608 Methods of using Fc-cytokine fusion proteins
10/25/2011	CA2544462C Immortalized avian cell lines for virus production
10/25/2011	CA2448329C Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
10/25/2011	CA2415923C Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers
10/25/2011	CA2395499C Chlamydia antigens and corresponding dna fragments and uses thereof
10/25/2011	CA2372709C Vector for integration of heterologous sequences into poxviral genomes
10/22/2011	CA2700466A1 Modification of intrinsically disordered sequences for the preparation of vaccines
10/20/2011	WO2011130753A2 Functionalized nano- and micro-materials for medical therapies
10/20/2011	WO2011130745A1 Compositions and methods for treating copd exacerbation
10/20/2011	WO2011130652A2 Compositions and methods for vaccinating humans and animals against enveloped viruses
10/20/2011	WO2011130650A2 Antibodies for the treatment of clostridium difficile-associated infection and disease
10/20/2011	WO2011130627A2 Chimpanzee adenoviral vector-based filovirus vaccines
10/20/2011	WO2011130611A2 Treating disorders associated with il-20 receptor-mediated signaling pathway by blocking il-20 receptor activity
10/20/2011	WO2011130603A2 Anti-vla-4 antibodies
10/20/2011	WO2011130572A1 Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
10/20/2011	WO2011130566A2 Method for treating solid tumors
10/20/2011	WO2011130499A1 Anti-polyubiquitin antibodies and methods of use
10/20/2011	WO2011130404A1 Process for treatment of amyotrophic lateral sclerosis, rheumatoid arthritis, tremors/parkinson's disease, multiple sclerosis, non-viral based cancers, alzheimer's disease, muscular dystrophy, attention deficit disorder, attention deficit hyperactivity disorder, complex regional pain syndrome, diabetes, neuropathic pain, spider arthritis, west nile virus, fibromyalgia, shingles, gout, migraine headaches, senile dementia, post polio syndrome, central virus deafness, asthma, chronic pain of unknown origin and hepatitis c
10/20/2011	WO2011130324A1 Fibronectin type iii domain-based multimeric scaffolds
10/20/2011	WO2011130301A2 Method of diagnosing and treating melioidosis
10/20/2011	WO2011130249A2 Methods and compositions for inhibition of treg cells
10/20/2011	WO2011130164A2 Unconjugated anti-tfr antibodies and compositions thereof for the treatment of cancer
10/20/2011	WO2011130125A1 Expression of positive sense single stranded rna virus and uses thereof
10/20/2011	WO2011129427A1 Diagnostic agent and therapeutic agent for cancer
10/20/2011	WO2011129379A1 Novel anti-hsp90 monoclonal antibody
10/20/2011	WO2011129348A1 Composition for treatment of cancer which is produced from cancer-tissue-derived cell mass or cancer cell aggregate, and process for production of immunotherapeutic agent and method for evaluation of efficacy of immunotherapy both using the composition
10/20/2011	WO2011129120A1 Methods and compositions for intranasal delivery
10/20/2011	WO2011128720A1 Trans-activator of transcription protein
10/20/2011	WO2011128704A1 Poxvirus expression system
10/20/2011	WO2011128642A1 Compoisitons comprising polyglutamic acid nanoparticles and polypeptides such as cd40 agonists
10/20/2011	WO2011128430A1 Method of vaccination
10/20/2011	WO2011128424A1 Methods and compositions for improving implant osseointegration
10/20/2011	WO2011128415A1 Cross-protecting vaccine for porcine reproductive and respiratory syndrome virus
10/20/2011	WO2011128247A1 N-terminal hpv e7 fusion proteins
10/20/2011	WO2011127989A1 Nicotine conjugate vaccine
10/20/2011	WO2011127936A1 Novel treatment for autoimmune diseases
10/20/2011	WO2011127924A2 Agent for locally treating cervical dysplasias
10/20/2011	WO2011127543A1 Proteins that bind pi16 and uses thereof
10/20/2011	WO2011127519A1 Combination treatment with vegf-c antagonists
10/20/2011	WO2011100700A3 Antigenic mimics of discontinuous epitopes of pathogen recognized by broadly neutralizing antibodies
10/20/2011	WO2011098762A8 Antibodies
10/20/2011	WO2011084882A3 Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
10/20/2011	WO2011084783A3 Novel pneumovirus compositions and methods for using the same
10/20/2011	WO2011083088A3 Methods for treating colorectal cancer
10/20/2011	WO2011075636A3 Wise binding agents and epitopes
10/20/2011	WO2011066417A3 Antibodies and conjugates for modulators of angiogenesis
10/20/2011	WO2011066374A3 Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
10/20/2011	WO2011066371A3 Antibodies to il-6 and use thereof
10/20/2011	WO2011063263A3 Methods for producing an immune response to tuberculosis
10/20/2011	WO2011056954A3 Haemophilus parasuis polypeptides and methods of use
10/20/2011	WO2011043584A3 Highly pathogenic avian influenza virus protein vaccine derived from transgenic plants, and method for preparing same
10/20/2011	WO2011038110A3 Methods of treating metabolic disease
10/20/2011	US20110257458 Method of using tumor cell debris to reduce brain tumor recurrence or growth
10/20/2011	US20110257367 Allogeneic vaccine and methods to synthesize same
10/20/2011	US20110257229 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
10/20/2011	US20110256533 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance
10/20/2011	US20110256217 Pulsatile release compositions and methods for enhanced intestinal drug absorption
10/20/2011	US20110256215 Non-pegylated liposomal doxorubicin triple combination therapy
10/20/2011	US20110256214 Single-time vaccines
10/20/2011	US20110256184 Non-ordered Mesoporous Silica Structure for Biomolecule Loading and Release
10/20/2011	US20110256182 Genes encoding major capsid protein l1 of human papilloma virus
10/20/2011	US20110256181 Recombinant bacterium capable of eliciting a protective immune response against c. perfringens
10/20/2011	US20110256180 Factor H Binding Proteins (FHBP) with Altered Properties and Methods of Use Thereof
10/20/2011	US20110256178 Borrellia burgdorferi bacterin
10/20/2011	US20110256177 Yersinia pestis vaccine
10/20/2011	US20110256176 Herpes simplex virus combined subunit vaccines and methods of use thereof
10/20/2011	US20110256175 Amino lipids and methods for the delivery of nucleic acids
10/20/2011	US20110256174 Rabies vaccine
10/20/2011	US20110256173 Chemical synthesis of phosphatidylinositol mannoside glycans from mycobacterium tuberculosis
10/20/2011	US20110256172 Epitope-targeted anthrax vaccine
10/20/2011	US20110256169 Novel polypeptides related to b-type natriuretic peptides and methods of their identification and use
10/20/2011	US20110256168 Conjugates that Contain the Homeodomain of Antennapedia
10/20/2011	US20110256167 Immunostimulating saponins for use in situ tumor-destruction therapy
10/20/2011	US20110256166 Multivalent vaccines comprising recombinant viral vectors
10/20/2011	US20110256165 Compositions of hsp60 peptides and viral antigens for vaccination and diagnosis
10/20/2011	US20110256164 Vaccine for the prevention of breast cancer recurrence
10/20/2011	US20110256163 Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy

1 ... 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 ... 1823